About Orpyx
Orpyx is a company based in Calgary (Canada) founded in 2010 by Marcel Groenland and Breanne Everett.. Orpyx has raised $25.61 million across 3 funding rounds from investors including Perceptive Advisors, Aphelion Capital and Thin Air Labs. Orpyx offers products and services including Sensory Insole System, Provider Dashboard, and Remote Patient Monitoring. Orpyx operates in a competitive market with competitors including Dexcom, mySugr, Levels, Biolinq and Indigo, among others.
- Headquarter Calgary, Canada
- Founders Marcel Groenland, Breanne Everett
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Orpyx Medical Technologies Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25.61 M (USD)
in 3 rounds
-
Latest Funding Round
$20 M (USD), Series B
Sep 24, 2024
-
Investors
Perceptive Advisors
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Orpyx
Orpyx offers a comprehensive portfolio of products and services, including Sensory Insole System, Provider Dashboard, and Remote Patient Monitoring. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Wearable insole that monitors pressure and temperature to prevent foot ulcers.
Tool for tracking patient data and insights in diabetes management.
Program offering virtual coaching and data analysis for diabetes care.
Unlock access to complete
Unlock access to complete
Funding Insights of Orpyx
Orpyx has successfully raised a total of $25.61M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $20.0M
-
First Round
First Round
(17 Jul 2020)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series B - Orpyx | Valuation | Perceptive Advisors |
|
| Oct, 2023 | Amount | Series A - Orpyx | Valuation |
investors |
|
| Jul, 2020 | Amount | Series A - Orpyx | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Orpyx
Orpyx has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Perceptive Advisors, Aphelion Capital and Thin Air Labs. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Tech and life sciences focused VC firm investing in geographies such as the US
|
Founded Year | Domain | Location | |
|
Thin Air Labs is engaged in venture capital and startup support services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Orpyx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orpyx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orpyx Comparisons
Competitors of Orpyx
Orpyx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, mySugr, Levels, Biolinq and Indigo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| domain | founded_year | HQ Location |
Gamified apps for diabetes management and therapy are provided.
|
|
| domain | founded_year | HQ Location |
Wearable devices for metabolic health insights are provided.
|
|
| domain | founded_year | HQ Location |
Wearable biosensor platform for real-time diabetes monitoring is provided.
|
|
| domain | founded_year | HQ Location |
Parking management and mobility solutions are provided by Indigo.
|
|
| domain | founded_year | HQ Location |
Continuous glucose monitoring system is provided for blood sugar levels.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Orpyx
Frequently Asked Questions about Orpyx
When was Orpyx founded?
Orpyx was founded in 2010 and raised its 1st funding round 10 years after it was founded.
Where is Orpyx located?
Orpyx is headquartered in Calgary, Canada. It is registered at Calgary, Alberta, Canada.
Who is the current CEO of Orpyx?
Breanne Everett is the current CEO of Orpyx. They have also founded this company.
Is Orpyx a funded company?
Orpyx is a funded company, having raised a total of $25.61M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5.6M, raised on Jul 17, 2020.
What does Orpyx do?
Wearable devices for neuropathy patients and athletes. It develops a sensor-based product, Orpyx SI, the sensory insoles with remote patient monitoring allows users to manage and prevent diabetic foot ulcers and limb loss through advanced foot sensor technology and real-time analytics. The insoles can fit above the shoe and capture pressure data from the users feet. The pressure data is then wirelessly transmitted from the shoe inserts to a smartwatch. The smartwatch alerts the user at extreme pressure levels to modify their behaviour and avoid damage. The device can be used to track neuropathy and is FDA cleared. Other product lines include SurroSense Rx system, Orpyx LogR solution and SurroGai Rx system.
What products or services does Orpyx offer?
Orpyx offers Sensory Insole System, Provider Dashboard, and Remote Patient Monitoring.
Who are Orpyx's investors?
Orpyx has 8 investors. Key investors include Perceptive Advisors, Aphelion Capital, Thin Air Labs, InterGen, and Relentless Venture Fund.